While Pso cells with DC markers maintained a CD14+, potentially LC-like phenotype (CD14+CD1a+CD11c+) [29], cells in eczema displayed a marker combination that included CD163 and/or CD63, hinting at a more differentiated DC that may constitute a DC3 subtype, as previously suggested [30,31]. This evidence concerns the gene ITGAX and Eczematoid dermatitis.